Kestra Medical Technologies, Ltd.
KMTS Healthcare Medical Instruments & Supplies
Kestra Medical Technologies, Ltd.’s revenue for fiscal 2026 (year ended April 2026) was $95.1 million, up 59.0% from fiscal 2025. In the quarter to July 2026, revenue grew 59.9%, EPS fell 50.0%, free cash flow fell 17.8% and total debt rose 74.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow KMTS
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
Net Income |
+3 more TTM periods Free account |
(131.48) | (143.89) | (131.61) | (149.87) |
Depreciation & Amortization |
9.60 | 10.00 | 10.48 | 10.16 | |
Non Cash Items (Other) |
42.63 | 51.80 | 37.66 | 51.73 | |
Accounts Receivable Change |
(7.79) | (7.11) | (9.06) | (7.33) | |
Accounts Payable Change |
0.82 | (1.47) | 4.30 | 5.32 | |
Change in payables and accrued liability |
3.35 | 6.08 | 8.20 | 4.33 | |
Change in other assets and liabilities |
(3.79) | (2.44) | (1.67) | (2.07) | |
Operating Cash Flow |
(86.67) | (87.04) | (81.70) | (87.72) | |
Capital expenditures |
(27.51) | (32.97) | (35.24) | (35.34) | |
Investing cash flow |
(27.51) | (37.97) | (203.28) | (216.40) | |
Repayment/Issuance of Debt (Net) |
— | — | — | 34.48 | |
Equity Repurchase (Common, Net) |
— | 367.45 | 368.05 | 370.49 | |
Dividends Paid (Total) |
— | (0.66) | (0.38) | (0.50) | |
Other financial activities |
(5.42) | (5.44) | (2.47) | (8.97) | |
Financing cash flow |
212.68 | 361.98 | 147.10 | 171.47 | |
Change in Cash |
98.51 | 236.97 | (137.88) | (132.66) | |
Beginning Cash |
237.93 | 237.93 | 237.93 | 100.04 | |
Ending Cash |
336.44 | 474.90 | 100.04 | (32.61) | |
Stock Based Compensation |
36.00 | 45.65 | 33.64 | 38.58 | |
Dividends Paid (Common) |
(0.06) | (0.03) | (0.32) | (0.49) | |
Assets Liabilities Change (Total) |
(7.42) | (4.94) | 1.78 | 0.25 | |
Investments Change (Net) |
— | (5.00) | (168.04) | (181.06) | |
Issuance/Purchase of Shares |
— | 367.45 | 368.05 | 370.49 |